Search Keyword:


Search option:


IID50269
UniprotP00520
ProteinTyrosine-protein kinase ABL1
GeneAbl1
OrganismMus musculus
Sequence LLPS PhaSepDB
PhaSePro
LLPSDB
DrLLPS
Network xml rdf
Structure
Experiment
  :order   disorder   conflict   PDB cluster   ProS   Pfam Domain   SEG
1123
 order/disorder by at least rule
     disorder by at least rule
     order by at least rule
 order/disorder by majority rule
Seq 27-515 Monomer :
 Evidence X-RAY 1opk A Reference
       Region 1opk A 27-63 disorder
       Region 1opk A 64-512 order
       Region 1opk A 513-515 disorder
Seq 61-121 Hetero dimer : IID50285Complex
 Evidence X-RAY 1abo B Reference
       Region 1abo B 61-63 disorder
       Region 1abo B 64-121 order
 Evidence X-RAY 1abo A Reference
       Region 1abo A 61-63 disorder
       Region 1abo A 64-121 order
Seq 61-121 Homo dimer :
 Evidence X-RAY 1abq A Reference
       Region 1abq A 61-64 disorder
       Region 1abq A 65-120 order
       Region 1abq A 121-121 disorder
Seq 229-515 Monomer :
 Evidence X-RAY 2z60 A Reference
       Region 2z60 A 229-275 order
       Region 2z60 A 276-278 disorder
       Region 2z60 A 279-511 order
       Region 2z60 A 512-515 disorder
 Evidence X-RAY 2qoh B Reference
       Region 2qoh B 229-274 order
       Region 2qoh B 275-277 disorder
       Region 2qoh B 278-511 order
       Region 2qoh B 512-515 disorder
 Evidence X-RAY 2qoh A Reference
       Region 2qoh A 229-275 order
       Region 2qoh A 276-278 disorder
       Region 2qoh A 279-501 order
       Region 2qoh A 502-515 disorder
 Evidence X-RAY 3oy3 B Reference
       Region 3oy3 B 229-511 order
 Evidence X-RAY 3oy3 A Reference
       Region 3oy3 A 229-511 order
 Evidence X-RAY 3oxz A Reference
       Region 3oxz A 229-273 order
       Region 3oxz A 274-279 disorder
       Region 3oxz A 280-385 order
       Region 3oxz A 386-392 disorder
       Region 3oxz A 393-394 order
       Region 3oxz A 395-397 disorder
       Region 3oxz A 398-511 order
 Evidence X-RAY 1opj B Reference
       Region 1opj B 229-512 order
       Region 1opj B 513-515 disorder
 Evidence X-RAY 1opj A Reference
       Region 1opj A 229-510 order
       Region 1opj A 511-515 disorder
 Evidence X-RAY 3mss D Reference
       Region 3mss D 229-231 disorder
       Region 3mss D 232-273 order
       Region 3mss D 274-279 disorder
       Region 3mss D 280-388 order
       Region 3mss D 389-389 disorder
       Region 3mss D 390-498 order
       Region 3mss D 499-515 disorder
 Evidence X-RAY 3mss C Reference
       Region 3mss C 229-231 disorder
       Region 3mss C 232-273 order
       Region 3mss C 274-279 disorder
       Region 3mss C 280-388 order
       Region 3mss C 389-389 disorder
       Region 3mss C 390-498 order
       Region 3mss C 499-515 disorder
 Evidence X-RAY 3mss B Reference
       Region 3mss B 229-231 disorder
       Region 3mss B 232-273 order
       Region 3mss B 274-279 disorder
       Region 3mss B 280-388 order
       Region 3mss B 389-389 disorder
       Region 3mss B 390-498 order
       Region 3mss B 499-515 disorder
 Evidence X-RAY 3mss A Reference
       Region 3mss A 229-231 disorder
       Region 3mss A 232-273 order
       Region 3mss A 274-279 disorder
       Region 3mss A 280-388 order
       Region 3mss A 389-389 disorder
       Region 3mss A 390-498 order
       Region 3mss A 499-515 disorder
 Evidence X-RAY 3ms9 B Reference
       Region 3ms9 B 229-273 order
       Region 3ms9 B 274-276 disorder
       Region 3ms9 B 277-498 order
       Region 3ms9 B 499-515 disorder
 Evidence X-RAY 3ms9 A Reference
       Region 3ms9 A 229-229 disorder
       Region 3ms9 A 230-273 order
       Region 3ms9 A 274-279 disorder
       Region 3ms9 A 280-387 order
       Region 3ms9 A 388-389 disorder
       Region 3ms9 A 390-498 order
       Region 3ms9 A 499-515 disorder
 Evidence X-RAY 1m52 B Reference
       Region 1m52 B 229-231 disorder
       Region 1m52 B 232-503 order
       Region 1m52 B 504-515 disorder
 Evidence X-RAY 1m52 A Reference
       Region 1m52 A 229-231 disorder
       Region 1m52 A 232-502 order
       Region 1m52 A 503-515 disorder
 Evidence X-RAY 3kfa B Reference
       Region 3kfa B 229-511 order
       Region 3kfa B 512-515 disorder
 Evidence X-RAY 3kfa A Reference
       Region 3kfa A 229-511 order
       Region 3kfa A 512-515 disorder
 Evidence X-RAY 3kf4 B Reference
       Region 3kf4 B 229-273 order
       Region 3kf4 B 274-276 disorder
       Region 3kf4 B 277-501 order
       Region 3kf4 B 502-515 disorder
 Evidence X-RAY 3kf4 A Reference
       Region 3kf4 A 229-274 order
       Region 3kf4 A 275-279 disorder
       Region 3kf4 A 280-514 order
       Region 3kf4 A 515-515 disorder
 Evidence X-RAY 3k5v B Reference
       Region 3k5v B 229-274 order
       Region 3k5v B 275-277 disorder
       Region 3k5v B 278-510 order
       Region 3k5v B 511-515 disorder
 Evidence X-RAY 3k5v A Reference
       Region 3k5v A 229-276 order
       Region 3k5v A 277-277 disorder
       Region 3k5v A 278-510 order
       Region 3k5v A 511-515 disorder
 Evidence X-RAY 3ik3 B Reference
       Region 3ik3 B 229-513 order
 Evidence X-RAY 3ik3 A Reference
       Region 3ik3 A 229-385 order
       Region 3ik3 A 386-391 disorder
       Region 3ik3 A 392-513 order
 Evidence X-RAY 1iep B Reference
       Region 1iep B 229-498 order
       Region 1iep B 499-515 disorder
 Evidence X-RAY 1iep A Reference
       Region 1iep A 229-498 order
       Region 1iep A 499-515 disorder
 Evidence X-RAY 2hzn A Reference
       Region 2hzn A 229-250 order
       Region 2hzn A 251-253 disorder
       Region 2hzn A 254-273 order
       Region 2hzn A 274-275 disorder
       Region 2hzn A 276-501 order
       Region 2hzn A 502-515 disorder
 Evidence X-RAY 1fpu B Reference
       Region 1fpu B 229-386 order
       Region 1fpu B 387-391 disorder
       Region 1fpu B 392-499 order
       Region 1fpu B 500-515 disorder
 Evidence X-RAY 1fpu A Reference
       Region 1fpu A 229-499 order
       Region 1fpu A 500-515 disorder
 Evidence X-RAY 3dk7 B Reference
       Region 3dk7 B 233-273 order
       Region 3dk7 B 274-277 disorder
       Region 3dk7 B 278-505 order
 Evidence X-RAY 3dk7 A Reference
       Region 3dk7 A 233-274 order
       Region 3dk7 A 275-278 disorder
       Region 3dk7 A 279-502 order
       Region 3dk7 A 503-505 disorder
 Evidence X-RAY 3dk6 B Reference
       Region 3dk6 B 233-233 disorder
       Region 3dk6 B 234-247 order
       Region 3dk6 B 248-254 disorder
       Region 3dk6 B 255-273 order
       Region 3dk6 B 274-278 disorder
       Region 3dk6 B 279-505 order
       Region 3dk6 B 506-514 disorder
 Evidence X-RAY 3dk6 A Reference
       Region 3dk6 A 233-248 order
       Region 3dk6 A 249-250 disorder
       Region 3dk6 A 251-273 order
       Region 3dk6 A 274-278 disorder
       Region 3dk6 A 279-502 order
       Region 3dk6 A 503-514 disorder
 Evidence X-RAY 3dk3 B Reference
       Region 3dk3 B 233-273 order
       Region 3dk3 B 274-277 disorder
       Region 3dk3 B 278-505 order
       Region 3dk3 B 506-514 disorder
 Evidence X-RAY 3dk3 A Reference
       Region 3dk3 A 233-274 order
       Region 3dk3 A 275-278 disorder
       Region 3dk3 A 279-502 order
       Region 3dk3 A 503-514 disorder
Seq 757-765 Hetero dimer : Q64010
 Evidence X-RAY 5ih2 N Reference
       Region 5ih2 N 757-765 order
 Evidence X-RAY 5ih2 M Reference
       Region 5ih2 M 757-765 order
SeqProS predicted 757-765 The unbound state of this region is predicted to be disordered by DICHOT and MobiDB. Hetero dimer : Q64010
       Region 5ih2 M 757-765 order
       Region 5ih2 N 757-765 order
Seqphosphorylation
    970-970 Phosphoserine
    909-909 Phosphoserine
    844-844 Phosphothreonine
    821-821 Phosphothreonine
    812-812 Phosphothreonine
    750-750 Phosphothreonine
    734-734 Phosphothreonine
    717-717 Phosphoserine
    682-682 Phosphoserine
    658-658 Phosphoserine
    620-620 Phosphoserine
    619-619 Phosphoserine; by PAK2
    618-618 Phosphoserine; by PAK2
    569-569 Phosphoserine
    559-559 Phosphoserine
    547-547 Phosphothreonine
    446-446 Phosphoserine
    413-413 Phosphotyrosine
    393-393 Phosphotyrosine; by autocatalysis and SRC-type Tyr-kinases
    257-257 Phosphotyrosine
    253-253 Phosphotyrosine
    229-229 Phosphoserine
    226-226 Phosphotyrosine; by autocatalysis
    215-215 Phosphotyrosine
    185-185 Phosphotyrosine
    172-172 Phosphotyrosine
    139-139 Phosphotyrosine
    128-128 Phosphotyrosine
    115-115 Phosphotyrosine
    70-70 Phosphotyrosine; by autocatalysis
    50-50 Phosphoserine
Seqacetylation
    710-710 N6-acetyllysine; by EP300
 
Prediction
NeProc
Disorder 1-61,509-1047,1094-1103,1111-1123
Order 62-508,1048-1093,1104-1110
ProS 1-15,33-39,509-513,523-529,611-631,638-655,662-682,711-715,725-738,760-764,867-871,1014-1039,1111-1123
AlphaFold
Disorder 1-61,250-253,276-278,382-390,513-1018,1041-1045,1093-1105
Order 62-249,254-275,279-381,391-512,1019-1040,1046-1092,1106-1123
Pfam Hmmer
PF00018 64-119 3.6e-19
PF00017 127-202 1.3e-34
PF07714 242-493 3.8e-157
SEG 5-23 ,249-260 ,605-609 ,698-703 ,802-810 ,883-907 ,949-960 ,964-983
Function
Function in SwissProt
Non-receptor tyrosine-protein kinase that plays a role in many key processes linked to cell growth and survival such as cytoskeleton remodeling in response to extracellular stimuli, cell motility and adhesion, receptor endocytosis, autophagy, DNA damage response and apoptosis. Coordinates actin remodeling through tyrosine phosphorylation of proteins controlling cytoskeleton dynamics like WASF3 (involved in branch formation); ANXA1 (involved in membrane anchoring); DBN1, DBNL, CTTN, RAPH1 and ENAH (involved in signaling); or MAPT and PXN (microtubule-binding proteins). Phosphorylation of WASF3 is critical for the stimulation of lamellipodia formation and cell migration. Involved in the regulation of cell adhesion and motility through phosphorylation of key regulators of these processes such as BCAR1, CRK, CRKL, DOK1, EFS or NEDD9. Phosphorylates multiple receptor tyrosine kinases and more particularly promotes endocytosis of EGFR, facilitates the formation of neuromuscular synapses through MUSK, inhibits PDGFRB-mediated chemotaxis and modulates the endocytosis of activated B-cell receptor complexes. Other substrates which are involved in endocytosis regulation are the caveolin (CAV1) and RIN1. Moreover, ABL1 regulates the CBL family of ubiquitin ligases that drive receptor down-regulation and actin remodeling. Phosphorylation of CBL leads to increased EGFR stability. Involved in late-stage autophagy by regulating positively the trafficking and function of lysosomal components. ABL1 targets to mitochondria in response to oxidative stress and thereby mediates mitochondrial dysfunction and cell death. In response to oxidative stress, phosphorylates serine/threonine kinase PRKD2 at 'Tyr-717' (By similarity). ABL1 is also translocated in the nucleus where it has DNA-binding activity and is involved in DNA-damage response and apoptosis. Many substrates are known mediators of DNA repair: DDB1, DDB2, ERCC3, ERCC6, RAD9A, RAD51, RAD52 or WRN. Activates the proapoptotic pathway when the DNA damage is too severe to be repaired. Phosphorylates TP73, a primary regulator for this type of damage-induced apoptosis. Phosphorylates the caspase CASP9 on 'Tyr-191' and regulates its processing in the apoptotic response to DNA damage. Phosphorylates PSMA7 that leads to an inhibition of proteasomal activity and cell cycle transition blocks. Regulates T-cell differentiation in a TBX21-dependent manner (PubMed:21690296). Phosphorylates TBX21 on tyrosine residues leading to an enhancement of its transcriptional activator activity (PubMed:21690296).